chr17-78897589-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001243540.2(CEP295NL):c.44+4196T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 152,138 control chromosomes in the GnomAD database, including 9,125 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 9122 hom., cov: 32)
Exomes 𝑓: 0.19 ( 3 hom. )
Consequence
CEP295NL
NM_001243540.2 intron
NM_001243540.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.14
Publications
15 publications found
Genes affected
CEP295NL (HGNC:44659): (CEP295 N-terminal like) Predicted to enable microtubule binding activity. Predicted to be involved in regulation of centriole replication. Predicted to be located in motile cilium. Predicted to be active in centriole; centrosome; and cytosol. [provided by Alliance of Genome Resources, Apr 2022]
TIMP2 (HGNC:11821): (TIMP metallopeptidase inhibitor 2) This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.609 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CEP295NL | NM_001243540.2 | c.44+4196T>C | intron_variant | Intron 2 of 2 | ENST00000322630.3 | NP_001230469.1 | ||
| TIMP2 | NM_003255.5 | c.131-23670T>C | intron_variant | Intron 1 of 4 | ENST00000262768.11 | NP_003246.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CEP295NL | ENST00000322630.3 | c.44+4196T>C | intron_variant | Intron 2 of 2 | 2 | NM_001243540.2 | ENSP00000312767.2 | |||
| TIMP2 | ENST00000262768.11 | c.131-23670T>C | intron_variant | Intron 1 of 4 | 1 | NM_003255.5 | ENSP00000262768.6 |
Frequencies
GnomAD3 genomes AF: 0.270 AC: 41059AN: 151954Hom.: 9093 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
41059
AN:
151954
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.188 AC: 12AN: 64Hom.: 3 Cov.: 0 AF XY: 0.190 AC XY: 8AN XY: 42 show subpopulations
GnomAD4 exome
AF:
AC:
12
AN:
64
Hom.:
Cov.:
0
AF XY:
AC XY:
8
AN XY:
42
show subpopulations
African (AFR)
AF:
AC:
1
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
0
AN:
10
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
8
AN:
46
Other (OTH)
AF:
AC:
3
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.271 AC: 41144AN: 152074Hom.: 9122 Cov.: 32 AF XY: 0.263 AC XY: 19551AN XY: 74344 show subpopulations
GnomAD4 genome
AF:
AC:
41144
AN:
152074
Hom.:
Cov.:
32
AF XY:
AC XY:
19551
AN XY:
74344
show subpopulations
African (AFR)
AF:
AC:
25506
AN:
41434
American (AMR)
AF:
AC:
2369
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
494
AN:
3470
East Asian (EAS)
AF:
AC:
651
AN:
5166
South Asian (SAS)
AF:
AC:
422
AN:
4826
European-Finnish (FIN)
AF:
AC:
1297
AN:
10594
Middle Eastern (MID)
AF:
AC:
76
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9744
AN:
67980
Other (OTH)
AF:
AC:
510
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1179
2359
3538
4718
5897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
557
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.